{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:36:07Z","timestamp":1792701367810,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["H2020-SC1-BHC-2018-2020"],"award-info":[{"award-number":["H2020-SC1-BHC-2018-2020"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme Neurodegenerative Disease Research","doi-asserted-by":"publisher","award":["AC19\/00097"],"award-info":[{"award-number":["AC19\/00097"]}],"id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01AG056850-01A1"],"award-info":[{"award-number":["1R01AG056850-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AG056974"],"award-info":[{"award-number":["R21AG056974"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG061566"],"award-info":[{"award-number":["R01AG061566"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"Caixabank SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005205","name":"J&J Innovative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["PI22\/01403"],"award-info":[{"award-number":["PI22\/01403"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["PI20\/01473"],"award-info":[{"award-number":["PI20\/01473"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["PI17\/01474"],"award-info":[{"award-number":["PI17\/01474"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["PI22\/00258"],"award-info":[{"award-number":["PI22\/00258"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["PI19\/00335"],"award-info":[{"award-number":["PI19\/00335"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["N\\u00BA MIA.2021"],"award-info":[{"award-number":["N\\u00BA MIA.2021"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["M02.0005"],"award-info":[{"award-number":["M02.0005"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015496","name":"Center for Networked Biomedical Research on Neurodegenerative Diseases","doi-asserted-by":"publisher","award":["CNV-304-PRF-866"],"award-info":[{"award-number":["CNV-304-PRF-866"]}],"id":[{"id":"10.13039\/501100015496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015496","name":"Center for Networked Biomedical Research on Neurodegenerative Diseases","doi-asserted-by":"publisher","award":["CB18\/05\/00010"],"award-info":[{"award-number":["CB18\/05\/00010"]}],"id":[{"id":"10.13039\/501100015496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002943","name":"Departament d'Innovaci\u00f3, Universitats i Empresa, Generalitat de Catalunya","doi-asserted-by":"publisher","award":["SLT006\/17\/00119"],"award-info":[{"award-number":["SLT006\/17\/00119"]}],"id":[{"id":"10.13039\/501100002943","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016387","name":"Grifols SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004975","name":"Fundaci\u00f3n Bancaja","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FI20\/00215"],"award-info":[{"award-number":["FI20\/00215"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CD22\/00125"],"award-info":[{"award-number":["CD22\/00125"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012331","name":"Agentschap Innoveren en Ondernemen","doi-asserted-by":"publisher","award":["N\\u00BA PR067\/21"],"award-info":[{"award-number":["N\\u00BA PR067\/21"]}],"id":[{"id":"10.13039\/100012331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2021-122473OA-I00"],"award-info":[{"award-number":["PID2021-122473OA-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ebiom.2024.105345","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T23:48:16Z","timestamp":1726616896000},"page":"105345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Clinical value of plasma pTau181 to predict Alzheimer's disease pathology in a large real-world cohort of a memory clinic"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9567-4283","authenticated-orcid":false,"given":"Amanda","family":"Cano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Capdevila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Puerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Arranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Montrreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itziar","family":"de Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Garc\u00eda-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Oliv\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Garc\u00eda-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Sotolongo-Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelina","family":"Orellana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribel","family":"Ramis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maitee","family":"Rosende-Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Lle\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Fortea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Tartari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asunci\u00f3n","family":"Lafuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"P\u00e9rez-Cord\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalia","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela","family":"Sanabria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Alegret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3012-2864","authenticated-orcid":false,"given":"Xavier","family":"Morat\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"T\u00e1rraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Marqui\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3819-3245","authenticated-orcid":false,"given":"Daniel","family":"Alcolea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\u00e8","family":"Boada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ebiom.2024.105345_bib1","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/alz.13016","article-title":"2023 Alzheimer's disease facts and figures","volume":"19","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105345_bib2","first-page":"109","article-title":"Defining disease modifying therapy for Alzheimer's disease","volume":"4","author":"Cummings","year":"2017","journal-title":"J\u00a0Prev Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105345_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/acn3.166","article-title":"A\u00a0practical algorithm for managing Alzheimer\u2019s disease: what, when, and why?","volume":"2","author":"Cummings","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.ebiom.2024.105345_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jneumeth.2018.10.025","article-title":"Blood-based biomarkers for Alzheimer\u2019s disease \u2014 an update","volume":"319","author":"Zetterberg","year":"2019","journal-title":"J\u00a0Neurosci Methods"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105345_bib5","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1002\/alz.12756","article-title":"The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease","volume":"18","author":"Hansson","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105345_bib6","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/jamaneurol.2022.2967","article-title":"The ATN framework\u2014moving preclinical alzheimer disease to clinical relevance","volume":"79","author":"van der Flier","year":"2022","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105345_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13195-022-01143-z","article-title":"Clinical performance of an antibody\u2013free assay for plasma A\u03b242\/A\u03b240 to detect early alterations of Alzheimer\u2019s disease in individuals with subjective cognitive decline","volume":"15","author":"Pascual-Lucas","year":"2023","journal-title":"Alzheimer's Res Ther"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105345_bib8","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jalz.2019.03.009","article-title":"Plasma amyloid \u03b2 40\/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease","volume":"15","author":"Vergallo","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"15","key":"10.1016\/j.ebiom.2024.105345_bib9","doi-asserted-by":"crossref","first-page":"e1580","DOI":"10.1212\/WNL.0000000000009240","article-title":"Total A\u03b242\/A\u03b240 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis","volume":"94","author":"Doecke","year":"2020","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105345_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13195-022-01093-6","article-title":"Diagnostic value of plasma p-tau 181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias","volume":"14","author":"Baiardi","year":"2022","journal-title":"Alzheimer's Res Ther"},{"key":"10.1016\/j.ebiom.2024.105345_bib11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2020.05.011","article-title":"A\u00a0longitudinal examination of plasma neurofilament light and total tau for the clinical detection and monitoring of Alzheimer's disease","volume":"94","author":"Sugarman","year":"2020","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105345_bib12","article-title":"Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer's disease and vascular pathology","volume":"14","author":"Shir","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105345_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41398-020-01137-1","article-title":"Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease","volume":"11","author":"Chatterjee","year":"2021","journal-title":"Transl Psychiatry"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105345_bib14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/clinchem\/hvad018","article-title":"Plasma glial fibrillary acidic protein in the Alzheimer disease continuum: relationship to other biomarkers, differential diagnosis, and prediction of clinical progression","volume":"69","author":"Shen","year":"2023","journal-title":"Clin Chem"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105345_bib15","first-page":"1797","article-title":"Plasma p-tau 231 and p-tau 217 as state markers of amyloid-\u03b2 pathology in preclinical Alzheimer's disease","volume":"28","author":"Mil\u00e0-Alom\u00e0","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2024.105345_bib16","article-title":"Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in A\u03b2 pathology are detected","volume":"10","author":"Su\u00e1rez-Calvet","year":"2020","journal-title":"EMBO Mol Med"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105345_bib17","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/alz.12841","article-title":"Plasma and CSF biomarkers in a memory clinic: head-to-head comparison of phosphorylated tau immunoassays","volume":"19","author":"Ashton","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105345_bib18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41591-020-0762-2","article-title":"Diagnostic value of plasma phosphorylated tau 181 in Alzheimer's disease and frontotemporal lobar degeneration","volume":"26","author":"Thijssen","year":"2020","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105345_bib19","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","article-title":"Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease : a diagnostic performance and prediction modelling study using data from four prospective cohorts","volume":"19","author":"Karikari","year":"2020","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105345_bib20","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200861","article-title":"Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer's disease","volume":"217","author":"Barth\u00e9lemy","year":"2020","journal-title":"J\u00a0Exp Med"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105345_bib21","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/s41591-022-02074-w","article-title":"Differential roles of A\u03b242\/40, p-tau 231 and p-tau 217 for Alzheimer \u2019 s trial selection and disease monitoring","volume":"28","author":"Ashton","year":"2022","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105345_bib22","doi-asserted-by":"crossref","first-page":"e473","DOI":"10.1212\/WNL.0000000000201479","article-title":"Validity and performance of blood biomarkers for alzheimer disease to predict dementia risk in a large clinic-based cohort","volume":"100","author":"Planche","year":"2023","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105345_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00401-020-02195-x","article-title":"Plasma p-tau 181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline","volume":"140","author":"Lantero-Rodriguez","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105345_bib24","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3233\/JAD-160915","article-title":"Impact of recruitment methods in subjective cognitive decline","volume":"57","author":"Abdelnour","year":"2017","journal-title":"J\u00a0Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105345_bib25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jalz.2013.03.006","article-title":"Design of a comprehensive Alzheimer's disease clinic and research center in Spain to meet critical patient and family needs","volume":"10","author":"Boada","year":"2014","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105345_bib26","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3233\/JAD-210254","article-title":"BIOFACE: a prospective study of risk factors, cognition, and biomarkers in a cohort of individuals with early-onset mild cognitive impairment. Study rationale and research protocols","volume":"83","author":"Esteban de Antonio","year":"2021","journal-title":"J\u00a0Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105345_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12951-023-01793-7","article-title":"Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early\u2013onset mild cognitive impairment","volume":"21","author":"Cano","year":"2023","journal-title":"J\u00a0Nanobiotechnol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105345_bib28","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3233\/JAD-122002","article-title":"Longitudinal follow-up of 550 mild cognitive impairment patients: evidence for large conversion to dementia rates and detection of major risk factors involved","volume":"34","author":"Espinosa","year":"2013","journal-title":"J\u00a0Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105345_bib29","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1038\/s41467-021-22491-8","article-title":"Common variants in Alzheimer's disease and risk stratification by polygenic risk scores","volume":"12","author":"de Rojas","year":"2021","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105345_bib30","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jalz.2019.06.4950","article-title":"Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: the GR@ACE project","volume":"15","author":"Moreno-Grau","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ebiom.2024.105345_bib31","first-page":"597","article-title":"The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: a data set for biomarker discovery and validation in neurodegenerative disorders","volume":"5","author":"Alcolea","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ebiom.2024.105345_bib32","article-title":"Diagnostic performance of plasma A\u03b21-42, A\u03b21-40 and pTau 181 in the LUMIPULSE automated platform for the detection of Alzheimer disease","author":"Arranz","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.ebiom.2024.105345_bib33","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.3390\/ijms23136891","article-title":"Establishing in-house cutoffs of CSF Alzheimer\u2019 s disease biomarkers for the at (N) stratification of the Alzheimer center Barcelona cohort","volume":"23","author":"Orellana","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105345_bib34","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jalz.2014.03.003","article-title":"The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative","volume":"10","author":"Molinuevo","year":"2014","journal-title":"Alzheimers Dement"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105345_bib35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13195-019-0550-8","article-title":"Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer's disease","volume":"11","author":"Leit\u00e3o","year":"2019","journal-title":"Alzheimer's Res Ther"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105345_bib36","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41582-022-00665-2","article-title":"Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility","volume":"18","author":"Karikari","year":"2022","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105345_bib37","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13195-021-00939-9","article-title":"Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms","volume":"13","author":"Bayoumy","year":"2021","journal-title":"Alzheimer's Res Ther"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105345_bib38","doi-asserted-by":"crossref","first-page":"e1229","DOI":"10.1212\/WNL.0000000000012513","article-title":"Associations of fully automated CSF and novel plasma biomarkers with Alzheimer disease neuropathology at autopsy","volume":"97","author":"Grothe","year":"2021","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105345_bib39","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/brain\/awac333","article-title":"Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer\u2019s disease","volume":"146","author":"Janelidze","year":"2023","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105345_bib40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-022-02408-5","article-title":"Plasma biomarkers for Alzheimer \u2019 s Disease in relation to neuropathology and cognitive change","volume":"143","author":"Smirnov","year":"2022","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105345_bib41","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s43587-023-00403-3","article-title":"Blood biomarkers for Alzheimer's disease in clinical practice and trials","volume":"3","author":"Hansson","year":"2023","journal-title":"Nat Aging"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105345_bib42","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1038\/s41467-021-23620-z","article-title":"A\u00a0multicentre validation study of the diagnostic value of plasma neurofilament light","volume":"12","author":"Ashton","year":"2021","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105345_bib43","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1002\/alz.13455","article-title":"The potential clinical value of plasma biomarkers in Alzheimer's disease","volume":"19","author":"Blennow","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105345_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazards of hazard ratios","volume":"21","author":"Hern\u00e1n","year":"2010","journal-title":"Epidemiology"},{"key":"10.1016\/j.ebiom.2024.105345_bib45","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s41591-021-01348-z","article-title":"Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures","volume":"27","author":"Palmqvist","year":"2021","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105345_bib46","doi-asserted-by":"crossref","first-page":"e860","DOI":"10.1212\/WNL.0000000000201597","article-title":"Diagnostic performance and clinical applicability of blood-based biomarkers in a prospective memory clinic cohort","volume":"100","author":"Sarto","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2024.105345_bib47","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","article-title":"Plasma p-tau 231: a new biomarker for incipient Alzheimer's disease pathology","volume":"5","author":"Ashton","year":"2021","journal-title":"Acta Neuropathol"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105345_bib48","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s43587-023-00471-5","article-title":"A\u00a0two-step workflow based on plasma p-tau 217 to screen for amyloid \u03b2 positivity with further confirmatory testing only in uncertain cases","volume":"3","author":"Brum","year":"2023","journal-title":"Nat Aging"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424003815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424003815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:37:06Z","timestamp":1778873826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424003815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":48,"alternative-id":["S2352396424003815"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105345","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical value of plasma pTau181 to predict Alzheimer's disease pathology in a large real-world cohort of a memory clinic","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105345","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105345"}}